NCT07495956: cfMSC Therapy for Diabetes
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 30 planned
- Started
- 30 Jun 2027
- Primary completion
- 30 Jun 2029
- Arms
- Clonal fetal mesenchymal stem cells (cfMSCs) therapy for type II diabetes mellitus
- Results
- None posted
- 27 Mar 2026: Trial registered